| |
| |
|
| Insider
Information: |
Burke Willaim P |
| Relationship: |
Director |
| City: |
Braintree |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
392,609 |
|
|
Indirect Shares
|
10,000 |
|
|
| Direct
Value |
$2,935,998 |
|
|
|
Indirect Value
|
$60,400 |
|
|
| Total
Shares |
402,609 |
|
|
| Total
Value |
$2,996,398 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
6
|
|
Stock
price went up :
|
1
|
3
|
| Stock
price went down : |
1
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 56.1%
|
12.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Haemonetics Corp |
HAE |
EVP, Chief Financial O... |
2021-08-23 |
30,291 |
2016-10-25 |
0 |
Premium* |
|
|
Miromatrix Medical Inc. |
MIRO |
|
2023-12-13 |
0 |
2022-01-03 |
0 |
Premium* |
|
|
Viewray, Inc. |
VRAY |
Chief Financial Officer |
2023-03-01 |
356,318 |
2023-01-16 |
0 |
Premium* |
|
|
Axogen Inc |
AXGN |
Director |
2023-08-24 |
6,000 |
2023-08-23 |
10,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
49 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2019-06-12 |
4 |
S |
$109.37 |
$20,780 |
D/D |
(190) |
14,460 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-06-12 |
4 |
AS |
$89.29 |
$17,590 |
D/D |
(197) |
34,832 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2021-05-17 |
4 |
S |
$55.97 |
$12,257 |
D/D |
(219) |
11,118 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-05-15 |
4 |
S |
$100.44 |
$22,197 |
D/D |
(221) |
10,190 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2021-05-19 |
4 |
S |
$55.19 |
$13,135 |
D/D |
(238) |
35,185 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2019-06-07 |
4 |
S |
$103.38 |
$42,489 |
D/D |
(411) |
14,650 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2021-06-07 |
4 |
S |
$55.09 |
$22,642 |
D/D |
(411) |
34,774 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2018-06-07 |
4 |
S |
$92.73 |
$39,410 |
D/D |
(425) |
12,968 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-06-08 |
4 |
S |
$97.03 |
$62,002 |
D/D |
(639) |
12,695 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2018-10-26 |
4 |
S |
$101.69 |
$79,217 |
D/D |
(779) |
13,825 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2017-10-25 |
4 |
S |
$46.76 |
$39,325 |
D/D |
(841) |
13,393 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• – – |
2019-10-28 |
4 |
AS |
$120.33 |
$138,981 |
D/D |
(1,155) |
11,859 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-10-26 |
4 |
S |
$106.00 |
$123,066 |
D/D |
(1,161) |
11,337 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• – – |
2019-10-29 |
4 |
AS |
$122.69 |
$177,655 |
D/D |
(1,448) |
10,411 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2018-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
2,606 |
15,574 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2019-05-14 |
4 |
A |
$0.00 |
$0 |
D/D |
3,060 |
15,061 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-05-18 |
4 |
A |
$0.00 |
$0 |
D/D |
3,144 |
13,334 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2021-07-01 |
4 |
AS |
$66.60 |
$285,914 |
D/D |
(4,293) |
30,291 |
0 |
% |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2017-06-06 |
4 |
A |
$41.64 |
$232,476 |
D/D |
5,583 |
15,996 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2018-06-25 |
4 |
OE |
$41.64 |
$238,056 |
D/D |
5,717 |
21,291 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2019-10-01 |
4 |
OE |
$41.64 |
$238,098 |
D/D |
5,718 |
20,178 |
0 |
- |
|
| AXGN |
Axogen Inc |
Director |
– • – |
2023-08-24 |
4 |
A |
$6.31 |
$37,860 |
D/D |
6,000 |
6,000 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2018-06-25 |
4 |
AS |
$92.17 |
$616,341 |
D/D |
(6,687) |
14,604 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2019-10-01 |
4 |
AS |
$124.47 |
$901,198 |
D/D |
(7,164) |
13,014 |
0 |
- |
|
| HAE |
Haemonetics Corp |
EVP, Chief Financial Officer |
• • – |
2020-06-15 |
4 |
AS |
$87.71 |
$852,541 |
D/D |
(9,720) |
25,112 |
0 |
% |
|
49 Records found
|
|
Page 1 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
